We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results data.
- Authors
Chlebowski, Rowan T.; Aragaki, Aaron K.; Anderson, Garnet L.; Prentice, Ross L.
- Abstract
Our commentary1 presented the hypothesis that changes in menopausal hormone practices beginning in 2002, as initially described by Ravdin et al,2 may be a major contributor to differential breast cancer national time trends between Black and White women. This differential pattern of HT use between Black and White women supports our hypothesis with regard to how a long-observed breast cancer incidence advantage for Black women largely has dissipated over the past 20 years. Breast cancer after use of estrogen plus progestin and estrogen alone: analyses of data from 2 Women's Health Initiative randomized clinical trials.
- Subjects
HORMONE receptor positive breast cancer; HORMONE therapy; WOMEN'S health
- Publication
Cancer (0008543X), 2021, Vol 127, Issue 5, p813
- ISSN
0008-543X
- Publication type
Article
- DOI
10.1002/cncr.33260